4.6 Article

Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia

Journal

CELL CYCLE
Volume 19, Issue 12, Pages 1454-1465

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2020.1750814

Keywords

Urothelial carcinoma-associated 1; miR-296-3p; Myc; acute myeloid leukemia

Categories

Funding

  1. Key Project of Anhui Provincial Department of Education [KJ2019A0358]
  2. Key Project of Translational Medicine in Bengbu Medical College [BYTM2019034]
  3. Key Project of natural sciences in Bengbu Medical College [BYKY1743ZD]
  4. Science and Technology Development Fund Project of the First Affiliated Hospital of Bengbu Medical College [BYYFYKJ2018013]

Ask authors/readers for more resources

Acute myeloid leukemia (AML) is a common hematopoietic malignancy with a generally poor prognosis. Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been identified as an oncogene in various malignancies including AML. However, the role and mechanisms of UCA1 in AML tumorigenesis were incompletely understood. Hence, this study aims to investigate whether UCA1 regulates AML progression by miR-296-3p/Myc axis. Cell proliferation and apoptosis were evaluated by MTT assay and flow cytometry, respectively. Luciferase reporter assay was performed to analyze the interaction between miR-296-3p and UCA1 or Myc. The results showed that UCA1 knockdown inhibited proliferation and induced apoptosis in AML cells (U937 and HL60). Mechanistically, UCA1 acted as a sponge of miR-296-3p by binding to miR-296-3p. Myc, a target of miR-296-3p, was positively regulated by UCA1. Functional assay showed that the anti-AML effect of UCA1 knockdown could be abrogated by miR-296-3p inhibition and Myc overexpression. Moreover, UCA1 knockdown inhibited AML cell tumorigenesisin vivo, which was associated with regulation of miR-296-3p and Myc expression. In conclusion, UCA1 modulates AML progression by regulating miR-296-3p/Myc axis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available